Literature DB >> 17105725

Ceramide regulates atypical PKCzeta/lambda-mediated cell polarity in primitive ectoderm cells. A novel function of sphingolipids in morphogenesis.

Kannan Krishnamurthy1, Guanghu Wang, Jeane Silva, Brian G Condie, Erhard Bieberich.   

Abstract

In mammals, the primitive ectoderm is an epithelium of polarized cells that differentiates into all embryonic tissues. Our study shows that in primitive ectoderm cells, the sphingolipid ceramide was elevated and co-distributed with the small GTPase Cdc42 and cortical F-actin at the apicolateral cell membrane. Pharmacological or RNA interference-mediated inhibition of ceramide biosynthesis enhanced apoptosis and impaired primitive ectoderm formation in embryoid bodies differentiated from mouse embryonic stem cells. Primitive ectoderm formation was restored by incubation with ceramide or a ceramide analog. Ceramide depletion prevented plasma membrane translocation of PKCzeta/lambda, its interaction with Cdc42, and phosphorylation of GSK-3beta, a substrate of PKCzeta/lambda. Recombinant PKCzeta formed a complex with the polarity protein Par6 and Cdc42 when bound to ceramide containing lipid vesicles. Our data suggest a novel mechanism by which a ceramide-induced, apicolateral polarity complex with PKCzeta/lambda regulates primitive ectoderm cell polarity and morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17105725     DOI: 10.1074/jbc.M607779200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  The carboxyl-terminal domain of atypical protein kinase Czeta binds to ceramide and regulates junction formation in epithelial cells.

Authors:  Guanghu Wang; Kannan Krishnamurthy; Nagavedi S Umapathy; Alexander D Verin; Erhard Bieberich
Journal:  J Biol Chem       Date:  2009-03-20       Impact factor: 5.157

Review 2.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.

Authors:  Stefka Spassieva; Erhard Bieberich
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Making sense of glycosphingolipids in epithelial polarity.

Authors:  Vincent Hyenne; Michel Labouesse
Journal:  Nat Cell Biol       Date:  2011-09-18       Impact factor: 28.824

Review 4.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

Review 5.  It's a lipid's world: bioactive lipid metabolism and signaling in neural stem cell differentiation.

Authors:  Erhard Bieberich
Journal:  Neurochem Res       Date:  2012-01-14       Impact factor: 3.996

6.  Transcript analysis of stem cells.

Authors:  Alison V Nairn; Mitche dela Rosa; Kelley W Moremen
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

Review 7.  Sphingolipids in neurodegeneration (with focus on ceramide and S1P).

Authors:  Guanghu Wang; Erhard Bieberich
Journal:  Adv Biol Regul       Date:  2018-09-22

8.  Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.

Authors:  Motoshi Suzuki; Ke Cao; Seiichi Kato; Yuji Komizu; Naoki Mizutani; Kouji Tanaka; Chinatsu Arima; Mei Chee Tai; Kiyoshi Yanagisawa; Norie Togawa; Takahiro Shiraishi; Noriyasu Usami; Tetsuo Taniguchi; Takayuki Fukui; Kohei Yokoi; Keiko Wakahara; Yoshinori Hasegawa; Yukiko Mizutani; Yasuyuki Igarashi; Jin-ichi Inokuchi; Soichiro Iwaki; Satoshi Fujii; Akira Satou; Yoko Matsumoto; Ryuichi Ueoka; Keiko Tamiya-Koizumi; Takashi Murate; Mitsuhiro Nakamura; Mamoru Kyogashima; Takashi Takahashi
Journal:  J Clin Invest       Date:  2015-12-07       Impact factor: 14.808

9.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

10.  Transcript profiling and lipidomic analysis of ceramide subspecies in mouse embryonic stem cells and embryoid bodies.

Authors:  Hyejung Park; Christopher A Haynes; Alison V Nairn; Michael Kulik; Stephen Dalton; Kelley Moremen; Alfred H Merrill
Journal:  J Lipid Res       Date:  2009-09-28       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.